A Steadying Force in C-Suite: The Changing Role of Biopharma CFOs
PharmExec
JULY 8, 2022
COVID-19 pandemic, the challenging capital-markets climate in biotech, and a more innovative and specialty treatment focus has increased reliance on the finance arm as a key strategic cog.
Let's personalize your content